Sandra X. Franco
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10.
Journal: Future oncology (London, England)
Published: July 31, 2026
Multilocus Inherited Neoplasia Alleles Syndrome in a Patient With BRCA2-Associated Breast Cancer and MLH1-Related Lynch Syndrome.
Journal: Case reports in oncological medicine
Published: January 29, 2026
Challenges and Opportunities for Cancer Clinical Trials Development in Latin America.
Journal: JCO global oncology
Published: December 04, 2025
Economic benefit of expanding mammography screening for breast cancer in Colombia: A cost modelling analysis.
Journal: Public health in practice (Oxford, England)
Published: November 19, 2025
Evidence-Based Consensus on the Diagnosis and Treatment of Advanced HER2-Positive and HER2-Low Breast Cancer in Colombia.
Journal: Journal of clinical medicine
Published: October 30, 2025
Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
Journal: Journal of surgical oncology
Published: April 30, 2024
Genomic ancestry and cancer among Latin Americans.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 23, 2023
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Journal: Clinical drug investigation
Published: September 11, 2023
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Journal: Clinical drug investigation
Published: July 17, 2023
Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer - Proceedings from breast cancer expert group meeting.
Journal: BMC proceedings
Published: June 24, 2021
Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting.
Journal: Chinese clinical oncology
Published: April 10, 2020
Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
Journal: Journal of neuro-oncology
Published: June 13, 2017
Last Updated: 09/26/2026